Khulood H. Oudah , Mazin A.A. Najm , Mohamed K. El-Ashrey , Fadi M. Awadallah , Safinaz E.-S. Abbas , Daniela Vullo , Claudiu T. Supuran
{"title":"苯甲酰硫脲基羟肟酸衍生物及其类似物的设计、合成、生物学评价和硅研究","authors":"Khulood H. Oudah , Mazin A.A. Najm , Mohamed K. El-Ashrey , Fadi M. Awadallah , Safinaz E.-S. Abbas , Daniela Vullo , Claudiu T. Supuran","doi":"10.1016/j.rechem.2025.102157","DOIUrl":null,"url":null,"abstract":"<div><div>The present investigation reports the design, synthesis and structure elucidation <em>via</em> elemental analyses and spectral techniques of six benzoylthioureido derivatives <strong>6a, 6b,7a,7b, 8</strong> and <strong>13</strong>. Compounds <strong>7a,7b, 8</strong> and <strong>13</strong> were screened for their biological activity including carbonic anhydrase inhibition, anticancer, antimicrobial and antioxidant properties. The biological evaluation revealed a superior carbonic anhydrase inhibitory activity of compound <strong>8</strong> against hCAI (k<sub>i</sub> = 58.60 nM) along with a moderate activity toward hCAII (k<sub>i</sub> = 44.00 nM) compared to acetazolamide AAZ (k<sub>i</sub> = 250.00 and 12.10 nM), respectively. The anticancer activity did not show any remarkable cytotoxicity. Antimicrobial and antioxidant activities of the newly synthesized compounds in addition to three previously reported sulfonamide-based derivatives <strong>14a-c</strong> demonstrated that the tested compounds show a potent antibacterial activity against <em>P. aeruginosa</em> (MIC = 125–250 μg/mL) except <strong>14a</strong>, moreover, <strong>7a</strong>, <strong>8</strong> and <strong>13</strong> displayed a potent antifungal activity (MIC = 125 μg/mL) against <em>C. albicans</em>. Furthermore, compound <strong>14b</strong> revealed a potent antioxidant activity in ABTS and DPPH assays. A molecular docking study was performed to correlate hCAI and hCAII inhibition of compound <strong>8</strong> with its binding pattern in the active site of the enzyme. Additionally, ADMET prediction of the synthesized compounds showed favorable physicochemical characteristics.</div></div>","PeriodicalId":420,"journal":{"name":"Results in Chemistry","volume":"14 ","pages":"Article 102157"},"PeriodicalIF":4.2000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis, biological evaluation and in silico study of some benzoylthioureido based hydroxamic acid derivatives and their analogues\",\"authors\":\"Khulood H. Oudah , Mazin A.A. Najm , Mohamed K. El-Ashrey , Fadi M. Awadallah , Safinaz E.-S. Abbas , Daniela Vullo , Claudiu T. Supuran\",\"doi\":\"10.1016/j.rechem.2025.102157\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The present investigation reports the design, synthesis and structure elucidation <em>via</em> elemental analyses and spectral techniques of six benzoylthioureido derivatives <strong>6a, 6b,7a,7b, 8</strong> and <strong>13</strong>. Compounds <strong>7a,7b, 8</strong> and <strong>13</strong> were screened for their biological activity including carbonic anhydrase inhibition, anticancer, antimicrobial and antioxidant properties. The biological evaluation revealed a superior carbonic anhydrase inhibitory activity of compound <strong>8</strong> against hCAI (k<sub>i</sub> = 58.60 nM) along with a moderate activity toward hCAII (k<sub>i</sub> = 44.00 nM) compared to acetazolamide AAZ (k<sub>i</sub> = 250.00 and 12.10 nM), respectively. The anticancer activity did not show any remarkable cytotoxicity. Antimicrobial and antioxidant activities of the newly synthesized compounds in addition to three previously reported sulfonamide-based derivatives <strong>14a-c</strong> demonstrated that the tested compounds show a potent antibacterial activity against <em>P. aeruginosa</em> (MIC = 125–250 μg/mL) except <strong>14a</strong>, moreover, <strong>7a</strong>, <strong>8</strong> and <strong>13</strong> displayed a potent antifungal activity (MIC = 125 μg/mL) against <em>C. albicans</em>. Furthermore, compound <strong>14b</strong> revealed a potent antioxidant activity in ABTS and DPPH assays. A molecular docking study was performed to correlate hCAI and hCAII inhibition of compound <strong>8</strong> with its binding pattern in the active site of the enzyme. Additionally, ADMET prediction of the synthesized compounds showed favorable physicochemical characteristics.</div></div>\",\"PeriodicalId\":420,\"journal\":{\"name\":\"Results in Chemistry\",\"volume\":\"14 \",\"pages\":\"Article 102157\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Results in Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211715625001407\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Results in Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211715625001407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
摘要
本文报道了6个苯甲酰硫脲基衍生物6a、6b、7a、7b、8和13的设计、合成和结构解析。对化合物7a、7b、8和13进行了碳酸酐酶抑制、抗癌、抗菌和抗氧化等生物活性筛选。生物学评价表明,化合物8对hCAI的碳酸酐酶抑制活性(ki = 58.60 nM)优于乙酰唑胺AAZ (ki = 250.00和12.10 nM),对hCAI的抑制活性(ki = 44.00 nM)中等。抗肿瘤活性未表现出明显的细胞毒性。结果表明,除14a外,新合成的化合物对铜绿假单胞菌(P. aeruginosa, MIC = 125 ~ 250 μg/mL)具有较强的抑菌活性,7a、8和13对白色念珠菌(C. albicans, MIC = 125 μg/mL)具有较强的抑菌活性。此外,化合物14b在ABTS和DPPH实验中显示出强大的抗氧化活性。我们进行了分子对接研究,将化合物8的hCAI和hCAII抑制与其在酶活性位点的结合模式联系起来。此外,ADMET预测表明合成的化合物具有良好的物理化学特性。
Design, synthesis, biological evaluation and in silico study of some benzoylthioureido based hydroxamic acid derivatives and their analogues
The present investigation reports the design, synthesis and structure elucidation via elemental analyses and spectral techniques of six benzoylthioureido derivatives 6a, 6b,7a,7b, 8 and 13. Compounds 7a,7b, 8 and 13 were screened for their biological activity including carbonic anhydrase inhibition, anticancer, antimicrobial and antioxidant properties. The biological evaluation revealed a superior carbonic anhydrase inhibitory activity of compound 8 against hCAI (ki = 58.60 nM) along with a moderate activity toward hCAII (ki = 44.00 nM) compared to acetazolamide AAZ (ki = 250.00 and 12.10 nM), respectively. The anticancer activity did not show any remarkable cytotoxicity. Antimicrobial and antioxidant activities of the newly synthesized compounds in addition to three previously reported sulfonamide-based derivatives 14a-c demonstrated that the tested compounds show a potent antibacterial activity against P. aeruginosa (MIC = 125–250 μg/mL) except 14a, moreover, 7a, 8 and 13 displayed a potent antifungal activity (MIC = 125 μg/mL) against C. albicans. Furthermore, compound 14b revealed a potent antioxidant activity in ABTS and DPPH assays. A molecular docking study was performed to correlate hCAI and hCAII inhibition of compound 8 with its binding pattern in the active site of the enzyme. Additionally, ADMET prediction of the synthesized compounds showed favorable physicochemical characteristics.